Talk:Retrotope

This article is rated Start-class on Wikipedia's content assessment scale.
It is of interest to the following WikiProjects:

Companies Low‑importance

This article is within the scope of WikiProject Companies, a collaborative effort to improve the coverage of companies on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.CompaniesWikipedia:WikiProject CompaniesTemplate:WikiProject Companiescompany articles

Low This article has been rated as Low-importance on the project's importance scale.

WikiProject Companies To-do:

Here are some tasks awaiting attention:

Article requests : Wikipedia:Requested articles/Business and economics/Companies
Assess : Category:Unassessed company articles
Copyedit : Category:Company articles needing attention
Infobox : Category:Company articles needing infoboxes
Maintain : Portal:Companies
Stubs : Help expand stub articles located at Category:Company stubs
Other :
- Tag company articles with the {{portal|Companies}} template
- Tag company talk pages with the {{WikiProject Companies}} project banner
- Answer requests for comments

Pharmacology

	This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles
???	This article has not yet received a rating on the project's importance scale.

Contested deletion

This article should not be speedily deleted for lack of asserted importance because... I am currently working on it --Oitio (talk) 22:16, 10 April 2018 (UTC)[reply]

This article doesn't tell us what is important about this company. Google doesn't either. The only results are self-published info and press releases. They have a drug in phase I trials, but this is statistically unlikely to become a pharmaceutical product. Natureium (talk) 22:22, 10 April 2018 (UTC)[reply]

There are publications in scientific journals, we can add references. Shall we add more information about these orphan (rare) but debilitating and life-shortening (though not affecting cognition), neurodegeneration disorders to this article? The drug is single but it represents a fundamentally novel approach (heavy isotope nutrient) to otherwise incurable conditions. And it is not a recent development (WP is not news) - it has been in development over many years and now got to the stage of FDA approval and clinical trials with published results. Oitio (talk) 23:28, 10 April 2018 (UTC)[reply]

Refs from New Scientist added to confirm notability.Oitio (talk) 10:47, 11 April 2018 (UTC)[reply]

Bankruptcy and aftermath

Retrotope went through bankruptcy and was bought by a company named BioJiva (which I think was created for that purpose). See last paragraph of https://www.globenewswire.com/news-release/2022/09/15/2516727/0/en/BioJiva-Reports-Results-of-Pilot-Phase-2-Clinical-Trial-of-RT001-in-Patients-with-Amyotrophic-Lateral-Sclerosis-ALS.html and other pages found by Googling "BioJiva" together with "Retrotope" or "RT001".

I think this BioJiva is distinct from the Indian company Biojiva (with lower-case j): https://www.thecompanycheck.com/company/biojiva-healthcare-private-limited/U51909JH2019PTC012709

I'm not a Wikipedian; hope someone will incorporate this information, and likewise modify the page about RT001. 2600:1700:B8B8:40:E94E:1E42:36EB:1694 (talk) 20:04, 22 October 2022 (UTC)[reply]